ES2097835T3 - Acidos 8-vinil y 8-etinil-quinolon-carboxilicos. - Google Patents

Acidos 8-vinil y 8-etinil-quinolon-carboxilicos.

Info

Publication number
ES2097835T3
ES2097835T3 ES92111454T ES92111454T ES2097835T3 ES 2097835 T3 ES2097835 T3 ES 2097835T3 ES 92111454 T ES92111454 T ES 92111454T ES 92111454 T ES92111454 T ES 92111454T ES 2097835 T3 ES2097835 T3 ES 2097835T3
Authority
ES
Spain
Prior art keywords
carboxylic acids
vinyl
quinolon
ethynyl
quinolone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92111454T
Other languages
English (en)
Spanish (es)
Inventor
Uwe Dr Petersen
Thomas Dr Himmler
Thomas Dr Schenke
Andreas Dr Krebs
Klaus Dr Grohe
Klaus Klaus-Dieter Dr Bremm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2097835T3 publication Critical patent/ES2097835T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)
  • Paints Or Removers (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
ES92111454T 1991-07-19 1992-07-06 Acidos 8-vinil y 8-etinil-quinolon-carboxilicos. Expired - Lifetime ES2097835T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4123918A DE4123918A1 (de) 1991-07-19 1991-07-19 8-vinyl- und 8-ethinyl-chinoloncarbonsaeuren

Publications (1)

Publication Number Publication Date
ES2097835T3 true ES2097835T3 (es) 1997-04-16

Family

ID=6436512

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92111454T Expired - Lifetime ES2097835T3 (es) 1991-07-19 1992-07-06 Acidos 8-vinil y 8-etinil-quinolon-carboxilicos.

Country Status (22)

Country Link
EP (1) EP0523512B1 (OSRAM)
JP (1) JP3174405B2 (OSRAM)
KR (1) KR100240608B1 (OSRAM)
AT (1) ATE147733T1 (OSRAM)
AU (1) AU658901B2 (OSRAM)
CA (1) CA2073993A1 (OSRAM)
CZ (1) CZ282037B6 (OSRAM)
DE (2) DE4123918A1 (OSRAM)
DK (1) DK0523512T3 (OSRAM)
ES (1) ES2097835T3 (OSRAM)
FI (1) FI103043B (OSRAM)
GR (1) GR3022305T3 (OSRAM)
HU (1) HU219910B (OSRAM)
IE (1) IE80557B1 (OSRAM)
IL (1) IL102520A (OSRAM)
MX (1) MX9204110A (OSRAM)
NO (1) NO302886B1 (OSRAM)
PL (1) PL171910B1 (OSRAM)
RU (1) RU2077533C1 (OSRAM)
SK (1) SK219192A3 (OSRAM)
TW (1) TW201309B (OSRAM)
ZA (1) ZA925351B (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4121214A1 (de) * 1991-06-27 1993-01-14 Bayer Ag 7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
DE4230804A1 (de) * 1992-09-15 1994-03-17 Bayer Ag 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate
DE4303657A1 (de) * 1993-02-09 1994-08-11 Bayer Ag Neue Chinolon- und Naphthyridoncarbonsäurederivate
KR950018003A (ko) * 1993-12-09 1995-07-22 스미스클라인 비참 피엘씨 신규한 퀴놀론 유도체 및 그의 제조 방법
DE4418510A1 (de) * 1994-05-27 1995-11-30 Bayer Ag 1,9-überbrückte Thiazolol[3,4-a]chinolinderivate
DE4425659A1 (de) * 1994-07-20 1996-01-25 Bayer Ag Neue N1-diverse 6-Fluor-8-difluormethoxy substituierte Chinoloncarbonsäuren
DE4427530A1 (de) * 1994-08-04 1996-02-08 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
EP0882049B1 (de) * 1996-02-23 2002-11-20 Bayer Ag Gegebenenfalls substituierte 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo- 4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre derivate
ES2224235T3 (es) * 1996-04-19 2005-03-01 Wakunaga Pharmaceutical Co., Ltd. Nuevos derivados del acido piridonacarboxilico o sus sales y agentes antibacterianos que contienen los mismos como ingredientes activos.
WO1998024781A1 (en) * 1996-12-04 1998-06-11 Daiichi Pharmaceutical Co., Ltd. Substituted aminomethylpyrrolidine derivatives
AR013493A1 (es) 1997-09-15 2000-12-27 Procter & Gamble COMPUESTO DE QUINOLONA, SU USO PARA LA FABRICACIoN DE UN MEDICAMENTO Y COMPOSICIoN FARMACEUTICA QUE LO COMPRENDE
PT1666477E (pt) 2003-09-10 2013-08-28 Kyorin Seiyaku Kk Derivado de 7-(4-substituído-3-ciclopropilaminometil-1- pirrolidinil) quinolonecarboxílico
US7563805B2 (en) 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative
RU2420524C2 (ru) * 2005-05-19 2011-06-10 Дайити Санкио Компани, Лимитед Производные три- или тетра-замещенного-3-аминопирролидина
JP5073497B2 (ja) * 2005-09-28 2012-11-14 第一三共株式会社 テトラ置換−5−アザスピロ[2.4]へプタン誘導体の製法およびその光学活性中間体
MX2008012488A (es) 2006-03-28 2008-10-10 Procter & Gamble Un proceso de acoplamiento para preparar intermedios de quinolona.
KR101102288B1 (ko) 2006-03-28 2012-01-03 워너 칠콧 컴퍼니 엘엘씨 (3s,5s)-7-(3-아미노-5-메틸-피페리디닐)-1-사이클로프로필-1,4-다이하이드로-8-메톡시-4-옥소-3-퀴놀린카르복실산의 말레이트 염 및 다형체
EP2149571A4 (en) 2007-05-24 2010-09-01 Kyorin Seiyaku Kk MUTILINE DERIVATIVE WITH A RINGED, HETEROCYCLIC AND AROMATIC CARBOXYLIC ACID STRUCTURE IN A SUBSTITUTE AT POSITION 14
US11572357B2 (en) * 2018-05-09 2023-02-07 Bayer Animal Health Gmbh Quinoline derivatives
RU2757741C1 (ru) * 2021-03-01 2021-10-21 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Производное ципрофлоксацина, обладающее антибактериальной активностью в отношении антибиотикоустойчивых штаммов микроорганизмов

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123536A (en) * 1977-12-14 1978-10-31 Warner-Lambert Company Dialkyl ({[3-(alkoxycarbonyl)-1,4-dihydro-4-oxo-8-quinolinyl]amino}methylene)propanedioates
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
JPS62215572A (ja) * 1986-03-17 1987-09-22 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
US5047538A (en) * 1990-04-12 1991-09-10 Warner-Lambert Company Quinolinecarboxylic acid antibacterial agents

Also Published As

Publication number Publication date
KR100240608B1 (ko) 2000-03-02
ZA925351B (en) 1993-04-28
RU2077533C1 (ru) 1997-04-20
FI923268A0 (fi) 1992-07-16
EP0523512B1 (de) 1997-01-15
EP0523512A1 (de) 1993-01-20
JP3174405B2 (ja) 2001-06-11
IL102520A (en) 1997-07-13
TW201309B (OSRAM) 1993-03-01
SK279221B6 (sk) 1998-08-05
DK0523512T3 (da) 1997-06-30
KR930002320A (ko) 1993-02-22
JPH05262738A (ja) 1993-10-12
GR3022305T3 (en) 1997-04-30
HUT61741A (en) 1993-03-01
IL102520A0 (en) 1993-01-14
PL295331A1 (en) 1993-07-12
FI103043B1 (fi) 1999-04-15
CZ219192A3 (en) 1993-02-17
DE4123918A1 (de) 1993-01-21
CZ282037B6 (cs) 1997-04-16
CA2073993A1 (en) 1993-01-20
IE922348A1 (en) 1993-01-27
NO922639D0 (no) 1992-07-03
SK219192A3 (en) 1998-08-05
FI923268L (fi) 1993-01-20
AU658901B2 (en) 1995-05-04
NO302886B1 (no) 1998-05-04
DE59207880D1 (de) 1997-02-27
PL171910B1 (pl) 1997-06-30
ATE147733T1 (de) 1997-02-15
MX9204110A (es) 1993-08-01
HU219910B (hu) 2001-09-28
FI103043B (fi) 1999-04-15
IE80557B1 (en) 1998-09-23
HU9202349D0 (en) 1992-10-28
NO922639L (no) 1993-01-20
AU1966392A (en) 1993-01-21

Similar Documents

Publication Publication Date Title
ES2097835T3 (es) Acidos 8-vinil y 8-etinil-quinolon-carboxilicos.
FI932944L (fi) Amider av antibiot ge 2270 faktorer
FR2694497B1 (fr) Desodorisant de table.
FI916182A7 (fi) Kombinerad metod foer faststaellande av brand.
FI924028A7 (fi) Foerfarande foer framstaellning av olefiner ur laetta paraffiner
DE69213616D1 (de) Zerstäuber
FI923704A7 (fi) Sammanlaenkade koder anvaendande avkodare foer en digitalsignal
FI934411A7 (fi) Kinolonikarboksyylihappoja
FI933425L (fi) Avlaegsning av organiska flyktiga bestaondsdelar ur polymerloesningar och-dispersioner
DE69133019D1 (de) Imidazolyl-alkencarbonsäuren
NO933623D0 (no) Fungicid mikroorganisme
FI933263A7 (fi) Foerfarande foer framstaellning av fysostigminkarbamatderivat ur eserotoler
FI944846L (fi) Johtava lakkaformulaatti
DE69305714D1 (de) Abspaltbare Carbonsäuren
BR9305824A (pt) Composição composição curável ou composição de revestimento
NO920224D0 (no) Nedbrytningsresistent hagebruksbeholder i stoept tremasse
FI924445L (fi) Maerkning av kolvaeten
FI930532A7 (fi) Foerfarande foer separering av organiska bestaondsdelar ur gasblandningar
FR2671706B3 (fr) Revetement decoratif pour tables.
LV10920A (lv) 6-Hlor-5-fluor-3-(2-tenoil)-2-oksindol-1-karboksamida lizina sals
NO921346D0 (no) Selvstendig broennhull-maalersystem
DE59105006D1 (de) Carboxylgruppenhaltige Cyclohexanderivate.
FI924702L (fi) Sovensbestaendig latexfaerg
BR7100511U (pt) Pulverizador objetivo
DE69206979D1 (de) Zerstäuber

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 523512

Country of ref document: ES